Matrix Metalloproteinases' Role in Tumor Microenvironment

Adv Exp Med Biol. 2020:1245:97-131. doi: 10.1007/978-3-030-40146-7_5.

Abstract

Cancer cells evolve in the tumor microenvironment (TME) by the acquisition of characteristics that allow them to initiate their passage through a series of events that constitute the metastatic cascade. For this purpose, tumor cells maintain a crosstalk with TME non-neoplastic cells transforming them into their allies. "Corrupted" cells such as cancer-associated fibroblasts (CAFs), tumor-associated macrophages (TAMs), and tumor-associated neutrophils (TANs) as well as neoplastic cells express and secrete matrix metalloproteinases (MMPs). Moreover, TME metabolic conditions such as hypoxia and acidification induce MMPs' synthesis in both cancer and stromal cells. MMPs' participation in TME consists in promoting events, for example, epithelial-mesenchymal transition (EMT), apoptosis resistance, angiogenesis, and lymphangiogenesis. MMPs also facilitate tumor cell migration through the basement membrane (BM) and extracellular matrix (ECM). The aim of the present chapter is to discuss MMPs' contribution to the evolution of cancer cells, their cellular origin, and their influence in the main processes that take place in the TME.

Keywords: Acidosis; Adipocyte; Angiogenesis; CAFs; EMT; Hypoxia; Lymphangiogenesis; MMPs; Mast cells; Metastasis; TAMs; TANs; TIMPs; TME; “Warburg effect”.

Publication types

  • Review

MeSH terms

  • Epithelial-Mesenchymal Transition
  • Humans
  • Matrix Metalloproteinases*
  • Neoplasms* / blood supply
  • Neoplasms* / enzymology
  • Neoplasms* / pathology
  • Neovascularization, Pathologic
  • Tumor Microenvironment*

Substances

  • Matrix Metalloproteinases